Covance Not Cooling...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$88.09 0.64 | 0.73%
05/17/13 - 04:02 PM ET
Portfolios with JNJ
- Portfolio NameUser Type
- UserSlip's Portfolio
- Userralphd5-12
- ContributorStocks Fund Managers Love Q...
- ProGeorge Soros
- ContributorGame of Thrones Portfolio
- UserCapt Jer
- ContributorRocket Stocks for the Week ...
- ContributorShort Squeezes for the Week...
- UserQuicksilver55
- Userlennyvb Portfolio 1
Latest JNJ Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 05.17.13 | 08:05 pm
- ASCO '13 Preview: Gilead's Big Cancer Debut 05.15.13 | 06:05 pm
- 5 Stocks Boosting The Drugs Industry Higher 05.15.13 | 01:05 pm
- Stryker's Stock Looks Pricey 05.15.13 | 07:05 am
- A New Lineup For The American Heroes Portfolio 05.12.13 | 10:05 am
- What's Missing in the Market; 3 Short Ideas That Don't Work: Cramer's Best Blogs 05.11.13 | 04:05 pm
- Covidien Is Growing Where Others Don't 05.09.13 | 06:05 am
- 5 Stocks Advancing The Drugs Industry 05.07.13 | 01:05 pm
- Dow Today: Home Depot (HD) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 05.06.13 | 04:05 pm
- It's Pipeline That Matters Most 05.04.13 | 04:05 am
Press Releases for JNJ
- Janssen And Johnson & Johnson To Provide Webcast Presentation Of Simeprevir Phase 3 Clinical Data Presented At The International Liver Congress Of The European Association For The Study Of The Liver (EASL) - PR Newswire 05.02.13 | 05:05 pm
- Johnson & Johnson Announces Dividend Increase Of 8.2% - PR Newswire 04.25.13 | 10:04 am
- Johnson & Johnson To Host Pharmaceuticals Business Review - PR Newswire 04.23.13 | 10:04 am
- Johnson & Johnson Announces Sale Of Elan American Depositary Shares To Elan - PR Newswire 04.18.13 | 09:04 am
- Johnson & Johnson To Webcast Annual Meeting Of Shareholders - PR Newswire 04.11.13 | 07:04 am
- Look And Feel Great This Spring, Despite Allergy Symptoms - PR Newswire 04.09.13 | 07:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Johnson & Johnson To Host Analyst Conference Call On First-Quarter Results - PR Newswire 03.19.13 | 10:03 am
- Cordis Acquires Flexible Stenting Solutions, Inc. - Business Wire 03.12.13 | 09:03 am
- Johnson & Johnson Comments On Venezuelan Currency Devaluation - PR Newswire 02.25.13 | 07:02 am
Partner Headlines for JNJ
- Some Dividend ETFs Outperforming The S&P 500 - Investor's Business Daily 05.16.13 | 05:05 pm
- Nature's Sunshine Products, Inc. (NATR) Ex-Dividend Date Scheduled for May 16, 2013 - NASDAQ 05.15.13 | 01:05 pm
- Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for May 16, 2013 - NASDAQ 05.15.13 | 01:05 pm
- Dr. Marc Faber's Gloomy Market Outlook - Seeking Alpha 05.14.13 | 09:05 am
- Theravance, Glaxo, Elan Star In Biotech Soap Opera - Investor's Business Daily 05.13.13 | 05:05 pm
- Should the market's new highs scare you? - MSN Money 05.13.13 | 12:05 pm
- Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 14, 2013 - NASDAQ 05.13.13 | 11:05 am
- Alzheimer's keeps frustrating big pharma - MSN Money 05.13.13 | 10:05 am
- Buffett Style Valuation Of Johnson & Johnson - Seeking Alpha 05.13.13 | 09:05 am
- Johnson & Johnson: An Investment In A Healthcare Conglomerate That Cannot Go Wrong - Seeking Alpha 05.13.13 | 09:05 am
